OOO

ONCIMMUNE HLDNGS LS-,01

No trades
See on Supercharts

OCY fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Oncimmune Holdings Plc engages in diagnosing cancer. It is involved in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS. The company was founded in 2002 and is headquartered in Nottinghamshire, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

OCY does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company